We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Researchers at Dartmouth Hitchcock Medical Center have developed a way to diagnose Lyme disease earlier and more accurately than traditional testing methods. Over the past 30 years, Lyme disease has ...

Denver Broncos linebacker Alex Singleton was diagnosed with testicular cancer last week, just days before he helped his team win their most recent game. Reading time 2 minutes An NFL player’s routine ...

Artificial intelligence is transforming the everyday practice of medicine — from simplifying diagnostic workflows to helping clinicians make faster, more informed decisions. To explore how AI can ...

Oct 13 (Reuters) - Roche Diagnostics (ROG.S), opens new tab said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's (LLY.N), opens new tab blood test as an aid in the ...

Share on Pinterest Scientists are getting closer to accurately and quickly diagnosing chronic fatigue syndrome. Santi Nuñez/Stocksy There is no single test to diagnose chronic fatigue syndrome (CFS), ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

A new blood test uses a portable diagnostic system to detect various different diseases in just 15 minutes. The test could change the way we diagnose a wide range of infectious diseases. Here's what ...

Seniors experiencing memory problems and cognitive decline now have access to a new diagnostic blood test to detect Alzheimer’s disease. Labcorp this week unveiled the first Food and Drug ...

The Alzheimer's Association released its first comprehensive clinical practice guidelines for the diagnosis, treatment, and care of Alzheimer's disease (AD) at the end of July. This landmark document ...

Elon Musk-owned xAI is testing Grok 4.20, a new model update to Grok 4, which already competes with GPT-5 in some benchmarks, such as ARC-AGI 2. GPT-5 is one of the best models for coding, and it ...

The FDA approved the Oncomine Dx Target Test for identifying HER2-mutant NSCLC patients eligible for Hernexeos, an oral tyrosine kinase inhibitor. Hernexeos offers a new treatment option for ...